drugset / Trial / NCT03754218

Amnion Wound Covering for Enhanced Wound Healing

NCT03754218 ↗

Phase 0 Completed 7 enrolled Wake Forest University Health Sciences
Non-randomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this research study is to find our if human amnion membrane powder can be safely used as a covering for wounds and can improve the condition of skin graft donor sites. The amnion powder product is composed of "lyophilized" (freeze-dried), "gamma irradiation sterilized" (exposed to bacteria killing radiation) fragments of amniotic membrane.

Timeline

Start
2019-12-01
Primary completion
2023-11-22
Completion
2023-11-22

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Amnion Membrane Powder Other / unclassified — Topical

Indications

No indication recorded.